Literature DB >> 20852023

The antiretroviral lectin cyanovirin-N targets well-known and novel targets on the surface of Entamoeba histolytica trophozoites.

Andrea Carpentieri1, Daniel M Ratner, Sudip K Ghosh, Sulagna Banerjee, G Guy Bushkin, Jike Cui, Michael Lubrano, Martin Steffen, Catherine E Costello, Barry O'Keefe, Phillips W Robbins, John Samuelson.   

Abstract

Entamoeba histolytica, the protist that causes amebic dysentery and liver abscess, has a truncated Asn-linked glycan (N-glycan) precursor composed of seven sugars (Man(5)GlcNAc(2)). Here, we show that glycoproteins with unmodified N-glycans are aggregated and capped on the surface of E. histolytica trophozoites by the antiretroviral lectin cyanovirin-N and then replenished from large intracellular pools. Cyanovirin-N cocaps the Gal/GalNAc adherence lectin, as well as glycoproteins containing O-phosphodiester-linked glycans recognized by an anti-proteophosphoglycan monoclonal antibody. Cyanovirin-N inhibits phagocytosis by E. histolytica trophozoites of mucin-coated beads, a surrogate assay for amebic virulence. For technical reasons, we used the plant lectin concanavalin A rather than cyanovirin-N to enrich secreted and membrane proteins for mass spectrometric identification. E. histolytica glycoproteins with occupied N-glycan sites include Gal/GalNAc lectins, proteases, and 17 previously hypothetical proteins. The latter glycoproteins, as well as 50 previously hypothetical proteins enriched by concanavalin A, may be vaccine targets as they are abundant and unique. In summary, the antiretroviral lectin cyanovirin-N binds to well-known and novel targets on the surface of E. histolytica that are rapidly replenished from large intracellular pools.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852023      PMCID: PMC2976296          DOI: 10.1128/EC.00166-10

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  56 in total

1.  Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions.

Authors:  Eddie W Adams; Daniel M Ratner; Heidi R Bokesch; James B McMahon; Barry R O'Keefe; Peter H Seeberger
Journal:  Chem Biol       Date:  2004-06

2.  Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.

Authors:  Barry R O'Keefe; Fakhrieh Vojdani; Viviana Buffa; Robin J Shattock; David C Montefiori; James Bakke; Jon Mirsalis; Anna-Lisa d'Andrea; Steven D Hume; Barry Bratcher; Carrie J Saucedo; James B McMahon; Gregory P Pogue; Kenneth E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

3.  Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.

Authors:  D Cameron Dunlop; Camille Bonomelli; Fatma Mansab; Snezana Vasiljevic; Katie J Doores; Mark R Wormald; Angelina S Palma; Ten Feizi; David J Harvey; Raymond A Dwek; Max Crispin; Christopher N Scanlan
Journal:  Glycobiology       Date:  2010-02-24       Impact factor: 4.313

4.  Absence of lipophosphoglycan-like glycoconjugates in Entamoeba dispar.

Authors:  A Bhattacharya; R Arya; C G Clark; J P Ackers
Journal:  Parasitology       Date:  2000-01       Impact factor: 3.234

5.  Members of the Entamoeba histolytica transmembrane kinase family play non-redundant roles in growth and phagocytosis.

Authors:  Sarah N Buss; Shinjiro Hamano; Alda Vidrich; Clive Evans; Yan Zhang; Oswald R Crasta; Bruno W Sobral; Carol A Gilchrist; William A Petri
Journal:  Int J Parasitol       Date:  2010-01-18       Impact factor: 3.981

6.  A lectin isolated from bananas is a potent inhibitor of HIV replication.

Authors:  Michael D Swanson; Harry C Winter; Irwin J Goldstein; David M Markovitz
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

7.  Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains.

Authors:  Robert J Luallen; Caroline Agrawal-Gamse; Hu Fu; David F Smith; Robert W Doms; Yu Geng
Journal:  Glycobiology       Date:  2009-11-17       Impact factor: 4.313

8.  The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans.

Authors:  S Moody-Haupt; J H Patterson; D Mirelman; M J McConville
Journal:  J Mol Biol       Date:  2000-03-24       Impact factor: 5.469

9.  EuPathDB: a portal to eukaryotic pathogen databases.

Authors:  Cristina Aurrecoechea; John Brestelli; Brian P Brunk; Steve Fischer; Bindu Gajria; Xin Gao; Alan Gingle; Greg Grant; Omar S Harb; Mark Heiges; Frank Innamorato; John Iodice; Jessica C Kissinger; Eileen T Kraemer; Wei Li; John A Miller; Vishal Nayak; Cary Pennington; Deborah F Pinney; David S Roos; Chris Ross; Ganesh Srinivasamoorthy; Christian J Stoeckert; Ryan Thibodeau; Charles Treatman; Haiming Wang
Journal:  Nucleic Acids Res       Date:  2009-11-13       Impact factor: 16.971

10.  Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence.

Authors:  Paul H Davis; Minghe Chen; Xiaochun Zhang; C Graham Clark; R Reid Townsend; Samuel L Stanley
Journal:  PLoS Negl Trop Dis       Date:  2009-04-14
View more
  3 in total

1.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

Review 2.  Effects of N-glycan precursor length diversity on quality control of protein folding and on protein glycosylation.

Authors:  John Samuelson; Phillips W Robbins
Journal:  Semin Cell Dev Biol       Date:  2014-12-02       Impact factor: 7.727

3.  Proteomic analysis of the cyst stage of Entamoeba histolytica.

Authors:  Ibne Karim M Ali; Rashidul Haque; Abdullah Siddique; Mamun Kabir; Nicholas E Sherman; Sean A Gray; Gerard A Cangelosi; William A Petri
Journal:  PLoS Negl Trop Dis       Date:  2012-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.